Jeroen van Eijk – Research output — Amsterdam UMC research portal

Research activity per year

1 Article

1 results

Filter

2023

Prospective trial of natalizumab personalised extended interval dosing by therapeutic drug monitoring in relapsing-remitting multiple sclerosis (NEXT-MS)
Toorop, A. A., van Lierop, Z. Y., Gelissen, L. M., Hoitsma, E., Zeinstra, E. M., van Rooij, L. C., van Munster, C. E., Vennegoor, A., Mostert, J. P., Wokke, B. H., Kalkers, N. F., Hoogervorst, E. L., van Eijk, J. J., Roosendaal, C. M., Kragt, J. J., Eurelings, M., van Genugten, J., Nielsen, J., Sinnige, L., Kloosterziel, M. E., & 16 othersArnoldus, E. P., van Dijk, G. W., Bouvy, W. H., Wessels, M. H., Boonkamp, L., Strijbis, E. M., van Oosten, B. W., De Jong, B. A., Lissenberg-Witte, B. I., Barkhof, F., Moraal, B., Teunissen, C. E., Rispens, T., Uitdehaag, B. M., Killestein, J. & van Kempen, Z. LE., 14 Nov 2023, (E-pub ahead of print) In: Journal of neurology, neurosurgery, and psychiatry.
Research output: Contribution to journal › Article › Academic

2 Citations (Scopus)